Servizio Comunitario di Informazione in materia di Ricerca e Sviluppo - CORDIS

FP7

HERMIONE-2MAN

Project ID: 601716
Finanziato nell'ambito di

First in Man Novel Anticancer Therapeutic based on Dependence Receptors Concept

Dal 2013-09-01 al 2016-08-31, progetto concluso | HERMIONE-2MAN Sito web

Dettagli del progetto

Costo totale:

EUR 7 750 543

Contributo UE:

EUR 5 962 231

Coordinato in:

France

Invito a presentare proposte:

FP7-HEALTH-2013-INNOVATION-2See other projects for this call

Meccanismo di finanziamento:

CP-FP - Small or medium-scale focused research project

Obiettivo

Coordinatore

CENTRE ANTICANCEREUX LEON BERARD
France

Contributo UE: EUR 1 587 623


RUE LAENNEC 28
69373 LYON
France
Activity type: Research Organisations
Contatto amministrativo: Marina Rousseau-Tsangaris
Tel.: +33 04 78 78 26 18
Fax: +33 4 78 78 29 55
E-mail

Partecipanti

NETRIS PHARMA SAS
France

Contributo UE: EUR 2 037 900


RUE LAENNEC 28 BATIMENT CHENEY C 28
69008 LYON
France
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Contatto amministrativo: Agnès Bernet
Tel.: +33 478785971
E-mail
POLYMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNG GMBH
Austria

Contributo UE: EUR 1 829 146


DONAUSTRASSE 99
3400 KLOSTERNEUBURG
Austria
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Contatto amministrativo: Dietmar Katinger
Tel.: +43 224325060303
E-mail
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL
Belgium

Contributo UE: EUR 507 562


Avenue E. Mounier 83
1200 Brussels
Belgium
Activity type: Research Organisations
Contatto amministrativo: Stéphane Lejeune
Tel.: +3227741075
E-mail

Argomenti

Life Sciences